These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 11429162

  • 1. Differential effects of phosphatidylinositol-3/Akt-kinase inhibition on apoptotic sensitization to cytokines in LNCaP and PCc-3 prostate cancer cells.
    Beresford SA, Davies MA, Gallick GE, Donato NJ.
    J Interferon Cytokine Res; 2001 May; 21(5):313-22. PubMed ID: 11429162
    [Abstract] [Full Text] [Related]

  • 2. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
    Chen X, Thakkar H, Tyan F, Gim S, Robinson H, Lee C, Pandey SK, Nwokorie C, Onwudiwe N, Srivastava RK.
    Oncogene; 2001 Sep 20; 20(42):6073-83. PubMed ID: 11593415
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells.
    Uddin S, Hussain AR, Al-Hussein KA, Manogaran PS, Wickrema A, Gutierrez MI, Bhatia KG.
    Clin Cancer Res; 2005 Apr 15; 11(8):3102-8. PubMed ID: 15837766
    [Abstract] [Full Text] [Related]

  • 4. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP.
    Rokhlin OW, Guseva NV, Tagiyev AF, Glover RA, Cohen MB.
    Prostate; 2002 Jun 01; 52(1):1-11. PubMed ID: 11992615
    [Abstract] [Full Text] [Related]

  • 5. Long-term androgen-ablation causes increased resistance to PI3K/Akt pathway inhibition in prostate cancer cells.
    Pfeil K, Eder IE, Putz T, Ramoner R, Culig Z, Ueberall F, Bartsch G, Klocker H.
    Prostate; 2004 Feb 15; 58(3):259-68. PubMed ID: 14743465
    [Abstract] [Full Text] [Related]

  • 6. eNOS protects prostate cancer cells from TRAIL-induced apoptosis.
    Tong X, Li H.
    Cancer Lett; 2004 Jul 08; 210(1):63-71. PubMed ID: 15172122
    [Abstract] [Full Text] [Related]

  • 7. Role of the phosphatidylinositol 3'-kinase/PTEN/Akt kinase pathway in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in non-small cell lung cancer cells.
    Kandasamy K, Srivastava RK.
    Cancer Res; 2002 Sep 01; 62(17):4929-37. PubMed ID: 12208743
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of phosphatidylinositol-3 kinase/Akt or mitogen-activated protein kinase signaling sensitizes endothelial cells to TNF-alpha cytotoxicity.
    Zhang L, Himi T, Morita I, Murota S.
    Cell Death Differ; 2001 May 01; 8(5):528-36. PubMed ID: 11423913
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of phosphatidylinositol 3'-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway.
    Uddin S, Hussain A, Al-Hussein K, Platanias LC, Bhatia KG.
    Biochem Biophys Res Commun; 2004 Jul 30; 320(3):932-8. PubMed ID: 15240138
    [Abstract] [Full Text] [Related]

  • 10. Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance.
    Thakkar H, Chen X, Tyan F, Gim S, Robinson H, Lee C, Pandey SK, Nwokorie C, Onwudiwe N, Srivastava RK.
    J Biol Chem; 2001 Oct 19; 276(42):38361-9. PubMed ID: 11461904
    [Abstract] [Full Text] [Related]

  • 11. PI3 Kinase inhibition on TRAIL-induced apoptosis correlates with androgen-sensitivity and p21 expression in prostate cancer cells.
    Kadowaki Y, Chari NS, Teo AE, Hashi A, Spurgers KB, McDonnell TJ.
    Apoptosis; 2011 Jun 19; 16(6):627-35. PubMed ID: 21437722
    [Abstract] [Full Text] [Related]

  • 12. Amiloride augments TRAIL-induced apoptotic death by inhibiting phosphorylation of kinases and phosphatases associated with the P13K-Akt pathway.
    Kim KM, Lee YJ.
    Oncogene; 2005 Jan 13; 24(3):355-66. PubMed ID: 15558024
    [Abstract] [Full Text] [Related]

  • 13. Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase.
    Cenni V, Maraldi NM, Ruggeri A, Secchiero P, Del Coco R, De Pol A, Cocco L, Marmiroli S.
    Int J Oncol; 2004 Dec 13; 25(6):1599-608. PubMed ID: 15547696
    [Abstract] [Full Text] [Related]

  • 14. Amiloride potentiates TRAIL-induced tumor cell apoptosis by intracellular acidification-dependent Akt inactivation.
    Cho YL, Lee KS, Lee SJ, Namkoong S, Kim YM, Lee H, Ha KS, Han JA, Kwon YG, Kim YM.
    Biochem Biophys Res Commun; 2005 Jan 28; 326(4):752-8. PubMed ID: 15607733
    [Abstract] [Full Text] [Related]

  • 15. Galectin-3 inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by activating Akt in human bladder carcinoma cells.
    Oka N, Nakahara S, Takenaka Y, Fukumori T, Hogan V, Kanayama HO, Yanagawa T, Raz A.
    Cancer Res; 2005 Sep 01; 65(17):7546-53. PubMed ID: 16140916
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis.
    Peuhu E, Rivero-Müller A, Stykki H, Torvaldson E, Holmbom T, Eklund P, Unkila M, Sjöholm R, Eriksson JE.
    Oncogene; 2010 Feb 11; 29(6):898-908. PubMed ID: 19935713
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells.
    Chaudhary LR, Hruska KA.
    J Cell Biochem; 2003 May 01; 89(1):1-5. PubMed ID: 12682902
    [Abstract] [Full Text] [Related]

  • 18. HER2 signaling downregulation by trastuzumab and suppression of the PI3K/Akt pathway: an unexpected effect on TRAIL-induced apoptosis.
    Dubská L, Andera L, Sheard MA.
    FEBS Lett; 2005 Aug 01; 579(19):4149-58. PubMed ID: 16023111
    [Abstract] [Full Text] [Related]

  • 19. Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis.
    Nesterov A, Lu X, Johnson M, Miller GJ, Ivashchenko Y, Kraft AS.
    J Biol Chem; 2001 Apr 06; 276(14):10767-74. PubMed ID: 11278284
    [Abstract] [Full Text] [Related]

  • 20. Regulation of TRAIL expression by the phosphatidylinositol 3-kinase/Akt/GSK-3 pathway in human colon cancer cells.
    Wang Q, Wang X, Hernandez A, Hellmich MR, Gatalica Z, Evers BM.
    J Biol Chem; 2002 Sep 27; 277(39):36602-10. PubMed ID: 12140294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.